Hollings Renton

Insider Reports History

Entity
Individual
Signature
/s/ Eric Loumeau, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hollings Renton:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ANAPTYSBIO, INC Director Common Stock 1.95K $60.4K $30.98 Jul 15, 2024 Direct
ANAPTYSBIO, INC Director Restricted Stock Unit 0 $0 $23.72 Jun 15, 2024 Direct
Zymeworks Inc. Director Stock Option (Right to Buy) 37K Dec 7, 2023 Direct
ANAPTYSBIO, INC Director Stock Option (right to buy) 16.5K Jan 3, 2024 Direct
Zymeworks Inc. Director Stock Option (Right to Buy) 9K May 6, 2021 Direct

Insider Reports Filed by Hollings Renton

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANAB ANAPTYSBIO, INC Jul 15, 2024 4 -$237K 4 Jul 17, 2024 Director
ANAB ANAPTYSBIO, INC Jun 15, 2024 3 -$45.2K 4 Jun 18, 2024 Director
ANAB ANAPTYSBIO, INC Jan 3, 2024 2 $0 4 Jan 5, 2024 Director
ZYME Zymeworks Inc. Dec 7, 2023 1 $0 4 Dec 8, 2023 Director
ANAB ANAPTYSBIO, INC Jan 6, 2023 2 $0 4 Jan 10, 2023 Director
ZYME Zymeworks Inc. Dec 21, 2022 1 $0 4 Dec 23, 2022 Director
ANAB ANAPTYSBIO, INC Feb 10, 2022 1 $0 4 Feb 14, 2022 Director
ZYME Zymeworks Inc. May 6, 2021 1 $0 4 May 7, 2021 Director